Cargando…

Effect of Levosimendan on Acute Decompensated Right Heart Failure in Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension

AIMS: Acute decompensated right heart failure (RHF) in chronic precapillary pulmonary hypertension is often typified by a swiftly progressive syndrome involving systemic congestion. This results from the impairment of the right ventricular filling and/or a reduction in the flow output of the right v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qu, Chao, Feng, Wei, Zhao, Qi, Liu, Qi, Luo, Xing, Wang, Gang, Sun, Meng, Yao, Zhibo, Sun, Yufei, Hou, Shenglong, Zhao, Chunyang, Zhang, Ruoxi, Qu, Xiufen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931274/ https://www.ncbi.nlm.nih.gov/pubmed/35308558 http://dx.doi.org/10.3389/fmed.2022.778620

Ejemplares similares

Levosimendan in pulmonary hypertension and right heart failure
por: Hansen, Mona Sahlholdt, et al.
Publicado: (2018)

Newer treatments for decompensated heart failure: focus on levosimendan
por: Follath, Ferenc
Publicado: (2009)

Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
por: Juguet, William, et al.
Publicado: (2020)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Levosimendan use in the emergency management of decompensated peripartum cardiomyopathy
por: Uriarte-Rodríguez, Alina, et al.
Publicado: (2010)

Levosimendan improves hemodynamic effects in patients with acutely decompensated heart failure: the Argentinean multicenter registry
por: Perrone, SV, et al.
Publicado: (2003)

Single-center experience with levosimendan in children undergoing cardiac surgery and in children with decompensated heart failure
por: Suominen, Pertti K
Publicado: (2011)

The effects of levosimendan use on high-sensitivity C-reactive protein in patients with decompensated heart failure
por: Korkmaz, Hasan, et al.
Publicado: (2019)

Levosimendan treatment for acutely decompensated heart failure is as effective for Chagas disease patients as for patients with other etiologies
por: Pereira-Barretto, AC, et al.
Publicado: (2003)

Levosimendan in Right Ventricular Dysfunction
por: Kapoor, Mukul C.
Publicado: (2023)

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004)

Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study
por: Çavuşoğlu, Yüksel, et al.
Publicado: (2016)

Hospital and intensive care unit management of decompensated pulmonary hypertension and right ventricular failure
por: Coz Yataco, Angel, et al.
Publicado: (2015)

Levosimendan improves cardiac function and myocardial efficiency in rats with right ventricular failure
por: Hansen, Mona S., et al.
Publicado: (2017)

Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
por: McLean, AS, et al.
Publicado: (2003)

Clinical outcomes of levosimendan versus dobutamine in patients with acute decompensated heart failure with reduced ejection fraction and impaired renal function
por: John, Basil, et al.
Publicado: (2021)

Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure
por: Lee, Wei-Chieh, et al.
Publicado: (2022)

A Case of Chronic Pulmonary Embolism Resulting in Pulmonary Hypertension and Decompensated Right Heart Failure
por: Hosna, Asma U, et al.
Publicado: (2022)

Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study
por: Garratt, C, et al.
Publicado: (2004)

Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in decompensated chronic heart failure patients treated with levosimendan
por: Ferri, MB, et al.
Publicado: (2006)

Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018)

Inhaled Levosimendan versus Intravenous Levosimendan in Patients with Pulmonary Hypertension Undergoing Mitral Valve Replacement
por: Kundra, Tanveer Singh, et al.
Publicado: (2018)

Critical Care Management of Decompensated Right Heart Failure in Pulmonary Arterial Hypertension Patients – An Ongoing Approach
por: Tilea, Ioan, et al.
Publicado: (2021)

The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure
por: Michalopoulou, H, et al.
Publicado: (2007)

Association of Repetitive Dosing of Levosimendan with Reduction of NYHA Class and NT-proBNP Levels in Decompensated Heart Failure: A Retrospective Cohort Study
por: Wechsler, Maximilian, et al.
Publicado: (2022)

Effect of levosimendan infusion prior to left ventricular assist device implantation on right ventricular failure
por: Segev, Amitai, et al.
Publicado: (2022)

Macrophage activating syndrome causing decompensated right heart failure
por: Chizinga, Mwelwa, et al.
Publicado: (2021)

A review of levosimendan in the treatment of heart failure
por: Kasikcioglu, Hulya Akhan, et al.
Publicado: (2006)

Levosimendan in trauma patients with acute cardiac failure
por: Afonin, AN, et al.
Publicado: (2011)

The Inhibition of Evolocumab on Non-Infarct-Related Artery Disease in Patients with ST-Elevation Myocardial Infarction
por: Zhao, Qi, et al.
Publicado: (2023)

Repetitive levosimendan treatment in the management of advanced heart failure
por: Oliva, Fabrizio, et al.
Publicado: (2018)

Use of Levosimendan in Patients with Advanced Heart Failure: An Update
por: Masarone, Daniele, et al.
Publicado: (2022)

Levosimendan Postconditioning Attenuates Cardiomyocyte Apoptosis after Myocardial Infarction
por: Xie, Ying, et al.
Publicado: (2022)

Decompensated heart failure
por: Mangini, Sandrigo, et al.
Publicado: (2013)

Preoperative Levosimendan therapy reduces postoperative right ventricular failure in patients undergoing left ventricular assist device implantation
por: Sugimura, Yukiharu, et al.
Publicado: (2023)

Effects of levosimendan on cardiac arrhythmia in patients with severe heart failure
por: Lilleberg, J, et al.
Publicado: (2002)

Hemodynamic effects of levosimendan in patients with low-output heart failure
por: Gharsallah, H, et al.
Publicado: (2008)

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

The inodilator levosimendan in repetitive doses in the treatment of advanced heart failure
por: Delgado, Juan F., et al.
Publicado: (2017)

Haemodynamic effects of levosimendan in advanced but stable chronic heart failure
por: Najjar, Emil, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rdv8t2pvhg560f32cl9bgvuij8